ARCHIVES

DCT Board Oks Limited Support For Development Of Neutron Therapy

This article is from The Cancer Letter archive.

Vol. 04 No. 13 | March 31, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCAB Committee Urged to Seek Surgical Oncology Certification

June 14, 1985

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

NIH Electronic Grant Coding System Worse Than NCI’s Manual Method, Advocates Say.

September 5, 2008

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982